• Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser1982Argfs*22 (c.5946delT) (6174delT); ClinVar=VCV000009325; Zygosity=Heterozygous (PubMed=26380221).
  

PubMed=24300787; DOI=10.1158/1078-0432.CCR-13-2053; PMCID=PMC3962776
Erdreich-Epstein A., Robison N., Ren X.-H., Zhou H., Xu J.-Y., Davidson T.B., Schur M., Gilles F.H., Ji L.-Y., Malvar J., Shackleford G.M., Margol A.S., Krieger M.D., Judkins A.R., Jones D.T.W., Pfister S.M., Kool M., Sposto R., Asgharzadeh S.
PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomas.
Clin. Cancer Res. 20:827-836(2014)

PubMed=25211508; DOI=10.1002/jcb.24976; PMCID=PMC10656279
Xu J., Margol A.S., Asgharzadeh S., Erdreich-Epstein A.
Pediatric brain tumor cell lines.
J. Cell. Biochem. 116:218-224(2015)

PubMed=26380221; DOI=10.3389/fonc.2015.00191; PMCID=PMC4550790
Xu J.-Y., Margol A.S., Shukla A., Ren X.-H., Finlay J.L., Krieger M.D., Gilles F.H., Couch F.J., Aziz M., Fung E.T., Asgharzadeh S., Barrett M.T., Erdreich-Epstein A.
Disseminated medulloblastoma in a child with germline BRCA2 6174delT mutation and without Fanconi anemia.
Front. Oncol. 5:191.1-191.12(2015)

PubMed=27498314; DOI=10.1016/j.jbiotec.2016.07.028
Ivanov D.P., Coyle B., Walker D.A., Grabowska A.M.
In vitro models of medulloblastoma: choosing the right tool for the job.
J. Biotechnol. 236:10-25(2016)

PubMed=27812533; DOI=10.1016/j.dib.2016.10.004; PMCID=PMC5079239
Ivanov D.P., Walker D.A., Coyle B., Grabowska A.M.
Data on the number and frequency of scientific literature citations for established medulloblastoma cell lines.
Data Brief 9:696-698(2016)